| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Interactive effects of homocysteine and copper on angiogenesis in porcine isolated saphenous vein.
|
Ann Thorac Surg
|
2007
|
1.48
|
|
2
|
Differential, time-dependent effects of perivenous application of fibrin glue on medial thickening in porcine saphenous vein grafts.
|
Eur J Cardiothorac Surg
|
2006
|
1.46
|
|
3
|
Saphenous vein harvest with the Mayo extraluminal dissector: is endothelial function preserved?
|
J Thorac Cardiovasc Surg
|
2008
|
1.39
|
|
4
|
Orally administered penicillamine is a potent inhibitor of neointimal and medial thickening in porcine saphenous vein-carotid artery interposition grafts.
|
J Thorac Cardiovasc Surg
|
2007
|
1.39
|
|
5
|
Exogenous hydrogen sulfide inhibits superoxide formation, NOX-1 expression and Rac1 activity in human vascular smooth muscle cells.
|
J Vasc Res
|
2008
|
1.15
|
|
6
|
Does oxidative stress change ceruloplasmin from a protective to a vasculopathic factor?
|
Atherosclerosis
|
2006
|
1.15
|
|
7
|
Iloprost inhibits superoxide formation and gp91phox expression induced by the thromboxane A2 analogue U46619, 8-isoprostane F2alpha, prostaglandin F2alpha, cytokines and endotoxin in the pig pulmonary artery.
|
Br J Pharmacol
|
2004
|
1.10
|
|
8
|
Sildenafil inhibits the formation of superoxide and the expression of gp47 NAD[P]H oxidase induced by the thromboxane A2 mimetic, U46619, in corpus cavernosal smooth muscle cells.
|
BJU Int
|
2005
|
1.10
|
|
9
|
Nitroaspirins and morpholinosydnonimine but not aspirin inhibit the formation of superoxide and the expression of gp91phox induced by endotoxin and cytokines in pig pulmonary artery vascular smooth muscle cells and endothelial cells.
|
Circulation
|
2004
|
1.06
|
|
10
|
Towards the treatment of saphenous vein bypass graft failure--a perspective of the Bristol Heart Institute.
|
Biorheology
|
2002
|
1.03
|
|
11
|
Long-term reduction of medial and intimal thickening in porcine saphenous vein grafts with a polyglactin biodegradable external sheath.
|
J Vasc Surg
|
2004
|
1.01
|
|
12
|
Characterization of the differential response of endothelial cells exposed to normal and elevated laminar shear stress.
|
J Cell Physiol
|
2011
|
0.99
|
|
13
|
Effect of hydrogen sulphide-donating sildenafil (ACS6) on erectile function and oxidative stress in rabbit isolated corpus cavernosum and in hypertensive rats.
|
BJU Int
|
2009
|
0.98
|
|
14
|
Sildenafil citrate and sildenafil nitrate (NCX 911) are potent inhibitors of superoxide formation and gp91phox expression in porcine pulmonary artery endothelial cells.
|
Br J Pharmacol
|
2005
|
0.98
|
|
15
|
Effect of sildenafil citrate and a nitric oxide donating sildenafil derivative, NCX 911, on cavernosal relaxation and superoxide formation in hypercholesterolaemic rabbits.
|
Eur J Pharmacol
|
2005
|
0.95
|
|
16
|
Sildenafil inhibits the up-regulation of phosphodiesterase type 5 elicited with nicotine and tumour necrosis factor-alpha in cavernosal vascular smooth muscle cells: mediation by superoxide.
|
BJU Int
|
2006
|
0.92
|
|
17
|
Superoxide auto-augments superoxide formation and upregulates gp91(phox) expression in porcine pulmonary artery endothelial cells: inhibition by iloprost.
|
Eur J Pharmacol
|
2006
|
0.92
|
|
18
|
Interactions between thromboxane A₂, thromboxane/prostaglandin (TP) receptors, and endothelium-derived hyperpolarization.
|
Cardiovasc Res
|
2014
|
0.92
|
|
19
|
A randomized trial of an external Dacron sheath for the prevention of vein graft disease: the Extent study.
|
J Thorac Cardiovasc Surg
|
2007
|
0.90
|
|
20
|
Nicotinamide adenine dinucleotide phosphate oxidase: a promiscuous therapeutic target for cardiovascular drugs?
|
Trends Cardiovasc Med
|
2005
|
0.88
|
|
21
|
Oxidative stress and vein graft failure: a focus on NADH oxidase, nitric oxide and eicosanoids.
|
Curr Opin Pharmacol
|
2012
|
0.86
|
|
22
|
The endothelin 1A receptor antagonist BSF 302146 is a potent inhibitor of neointimal and medial thickening in porcine saphenous vein-carotid artery interposition grafts.
|
J Thorac Cardiovasc Surg
|
2004
|
0.85
|
|
23
|
The administration of folic acid improves erectile function and reduces intracavernosal oxidative stress in the diabetic rabbit.
|
BJU Int
|
2008
|
0.85
|
|
24
|
Nitric oxide donating aspirins: novel drugs for the treatment of saphenous vein graft failure.
|
Ann Thorac Surg
|
2003
|
0.84
|
|
25
|
Penicillamine administration reverses the inhibitory effect of hyperhomocysteinaemia on endothelium-dependent relaxation and superoxide formation in the aorta of the rabbit.
|
Eur J Pharmacol
|
2006
|
0.83
|
|
26
|
NADPH oxidase 4 mediates upregulation of type 4 phosphodiesterases in human endothelial cells.
|
J Cell Physiol
|
2012
|
0.83
|
|
27
|
Homocysteine and copper interact to promote type 5 phosphodiesterase expression in rabbit cavernosal smooth muscle cells.
|
Asian J Androl
|
2008
|
0.83
|
|
28
|
Pathophysiology of saphenous vein graft failure: a brief overview of interventions.
|
Curr Opin Pharmacol
|
2012
|
0.83
|
|
29
|
The administration of folic acid reduces intravascular oxidative stress in diabetic rabbits.
|
Metabolism
|
2008
|
0.82
|
|
30
|
Nitric oxide-donating aspirin (NCX 4016) inhibits neointimal thickening in a pig model of saphenous vein-carotid artery interposition grafting: a comparison with aspirin and morpholinosydnonimine (SIN-1).
|
J Thorac Cardiovasc Surg
|
2007
|
0.81
|
|
31
|
Calcium and the replication of human vascular smooth muscle cells: studies on the activation and translocation of extracellular signal regulated kinase (ERK) and cyclin D1 expression.
|
Eur J Pharmacol
|
2005
|
0.81
|
|
32
|
NADPH oxidase 1 mediates upregulation of thromboxane A2 synthase in human vascular smooth muscle cells: inhibition with iloprost.
|
Eur J Pharmacol
|
2011
|
0.80
|
|
33
|
Low nanomolar thapsigargin inhibits the replication of vascular smooth muscle cells through reversible endoplasmic reticular stress.
|
Eur J Pharmacol
|
2013
|
0.78
|
|
34
|
Re: Oxidative stress in arteriogenic erectile dysfunction: prophylactic role of antioxidants.
|
J Urol
|
2006
|
0.77
|
|
35
|
Smoking and erectile dysfunction: the role of NADPH oxidase.
|
BJU Int
|
2004
|
0.77
|
|
36
|
Prednisolone augments superoxide formation in porcine pulmonary artery endothelial cells through differential effects on the expression of nitric oxide synthase and NADPH oxidase.
|
Br J Pharmacol
|
2005
|
0.77
|
|
37
|
Cavernosal dysfunction in a rabbit model of hyperhomocysteinaemia.
|
BJU Int
|
2005
|
0.77
|
|
38
|
Delayed recovery of receptor-mediated functional responses to acetylcholine in mouse isolated carotid arteries following endothelial denudation in vivo.
|
J Vasc Res
|
2003
|
0.76
|
|
39
|
Inhaled prostacyclin is safe, effective, and affordable in patients with pulmonary hypertension, right-heart dysfunction, and refractory hypoxemia after cardiothoracic surgery.
|
J Thorac Cardiovasc Surg
|
2004
|
0.76
|
|
40
|
Role of osteopontin in the development of neointimal hyperplasia in vein grafts.
|
Eur J Cardiothorac Surg
|
2011
|
0.76
|
|
41
|
Pharmacological strategies aimed at reducing complications associated with coronary artery bypass graft surgery.
|
Curr Opin Pharmacol
|
2012
|
0.76
|
|
42
|
Pre-clinical evidence for the use of phosphodiesterase-5 inhibitors for treating benign prostatic hyperplasia and lower urinary tract symptoms.
|
BJU Int
|
2006
|
0.76
|
|
43
|
Possible mechanisms underlying the effects of inhaled nitric oxide.
|
Anesthesiology
|
2007
|
0.75
|
|
44
|
To: Looker HC, Fagot-Campagna A, Gunter EW et al. (2003) Homocysteine as a risk factor for nephropathy and retinopathy in Type 2 diabetes. Diabetologia 46:766-772.
|
Diabetologia
|
2003
|
0.75
|
|
45
|
Sexual dysfunction and cardiac risk (the second Princeton Concensus Conference).
|
Am J Cardiol
|
2005
|
0.75
|
|
46
|
8-isoprostane F2α up-regulates the expression of type 5 phosphodiesterase in cavernosal vascular smooth muscle cells: inhibition with sildenafil, iloprost, nitric oxide and picotamide.
|
BJU Int
|
2010
|
0.75
|
|
47
|
Moderately elevated plasma homocysteine impairs functional endothelial recovery following denudation of mouse carotid arteries.
|
Metabolism
|
2004
|
0.75
|